[1] 2025 Alzheimer’s disease facts and figures. Alzheimers Dement, 2025; 21, e70235.
[2] Topol E. Predicting and preventing Alzheimer’s disease. Science, 2025; 388, eady3217. doi:  10.1126/science.ady3217
[3] Christodoulou RC, Eller D, Papageorgiou PS, et al. Metabolic dysfunction in Alzheimer’s disease: brain glucose hypometabolism as an early precursor to amyloid and tau pathology. J Clin Med, 2026; 15, 1884. doi:  10.3390/jcm15051884
[4] Xu LF, Liu R, Qin YK, et al. Brain metabolism in Alzheimer’s disease: biological mechanisms of exercise. Transl Neurodegener, 2023; 12, 33. doi:  10.1186/s40035-023-00364-y
[5] Patel V, Mill J, Okonkwo OC, et al. Global energy metabolism deficit in Alzheimer disease brain. J Prev Alzheimers Dis, 2024; 11, 171−8. doi:  10.14283/jpad.2023.91
[6] Kong JT, Wang MX, Zhang XZ, et al. Role of the gut-brain axis in chronotype-driven Alzheimer’s disease: a Mendelian randomization study. Biomed Environ Sci, 2025; 38, 519−24.
[7] Alhasan MS, Alhasan AS, Milburn J, et al. FDG-PET brain glucose hypometabolism predicts Alzheimer’s disease progression pathways in cognitively normal adults: a longitudinal competing risks modeling. Metabol Open, 2025; 28, 100400. doi:  10.1016/j.metop.2025.100400
[8] Constantino NJ, Ashley CC, Macauley SL. The energetic collapse of the Alzheimer’s brain: metabolic inflexibility across cells and networks. J Neurochem, 2025; 169, e70294. doi:  10.1111/jnc.70294
[9] Lee H, Kim BH, Lee EH, et al. Brain metabolic resilience in Alzheimer’s disease: a predictor of cognitive decline and conversion to dementia. Am J Geriatr Psychiatry, 2025; 33, 678−88. doi:  10.1016/j.jagp.2024.11.015
[10] Chen XY, Liu LL, Kang SW, et al. The lactate dehydrogenase (LDH) isoenzyme spectrum enables optimally controlling T cell glycolysis and differentiation. Sci Adv, 2023; 9, eadd9554. doi:  10.1126/sciadv.add9554
[11] Ma F, Yu W. The roles of lactate and lactylation in diseases related to mitochondrial dysfunction. Int J Mol Sci, 2025; 26, 7149. doi:  10.3390/ijms26157149
[12] Zhou YZ, Qi M, Yang MH. Current status and future perspectives of lactate dehydrogenase detection and medical implications: a review. Biosensors (Basel), 2022; 12, 1145. doi:  10.3390/bios12121145
[13] Gao WW, Cai LJ, Chen XY, et al. Dynamic serum lactate dehydrogenase monitoring during the acute phase and association with in-hospital all-cause mortality risk in large vessel occlusion acute ischemic stroke patients. Eur J Med Res, 2025; 30, 743. doi:  10.1186/s40001-025-03025-0
[14] Zhang HL, Kang K, Chen SJ, et al. High serum lactate dehydrogenase as a predictor of cardiac insufficiency at follow-up in elderly patients with acute myocardial infarction. Arch Gerontol Geriatr, 2024; 117, 105253. doi:  10.1016/j.archger.2023.105253
[15] Zebhauser PT, Berthele A, Goldhardt O, et al. Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers. Alzheimers Res Ther, 2022; 14, 61. doi:  10.1186/s13195-022-01004-9
[16] Hai SS, Hou YD, Zhang MY, et al. Glucose metabolism, lactate, lactylation and Alzheimer’s disease. Aging Dis, 2026; 17, 1850−67. doi:  10.14336/ad.2025.0338
[17] Liguori C, Stefani A, Sancesario G, et al. CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer’s disease. J Neurol Neurosurg Psychiatry, 2015; 86, 655−9. doi:  10.1136/jnnp-2014-308577
[18] Niccoli T, Kerr F, Snoeren I, et al. Activating transcription factor 4-dependent lactate dehydrogenase activation as a protective response to amyloid beta toxicity. Brain Commun, 2021; 3, fcab053. doi:  10.1093/braincomms/fcab053
[19] Yang CG, Pan RY, Guan FX, et al. Lactate metabolism in neurodegenerative diseases. Neural Regen Res, 2024; 19, 69−74. doi:  10.4103/1673-5374.374142
[20] Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement, 2011; 7, 270−9. doi:  10.1016/j.jalz.2011.03.008
[21] McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement, 2011; 7, 263−9. doi:  10.1016/j.jalz.2011.03.005
[22] Xu M, Zhang DF, Luo RC, et al. A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer’s disease. Alzheimers Dement, 2018; 14, 215−29. doi:  10.1016/j.jalz.2017.08.012
[23] Zhang DF, Fan Y, Xu M, et al. Complement C7 is a novel risk gene for Alzheimer’s disease in Han Chinese. Natl Sci Rev, 2019; 6, 257−74. doi:  10.1093/nsr/nwy127
[24] Darmanis S, Sloan SA, Zhang Y, et al. A survey of human brain transcriptome diversity at the single cell level. Proc Natl Acad Sci USA, 2015; 112, 7285−90. doi:  10.1073/pnas.1507125112
[25] Pan J, Fores-Martos J, Delpirou Nouh C, et al. Deciphering glial contributions to CSF1R-related disorder via single-nuclear transcriptomic profiling: a case study. Acta Neuropathol Commun, 2024; 12, 139. doi:  10.1186/s40478-024-01853-5
[26] Leng K, Li E, Eser R, et al. Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease. Nat Neurosci, 2021; 24, 276−87. doi:  10.1038/s41593-020-00764-7
[27] Rexach JE, Cheng YY, Chen L, et al. Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics. Cell, 2024; 187, 5753-74. e28.
[28] CZI Cell Science Program, Abdulla S, Aevermann B, et al. CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data. Nucleic Acids Res, 2025; 53, D886−D900. doi:  10.1093/nar/gkae1142
[29] Wu YL, Lu CX, Pan NN, et al. Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases. Sci Rep, 2021; 11, 12997. doi:  10.1038/s41598-021-92430-6
[30] Muramatsu D, Watanabe-Nakayama T, Tsuji M, et al. ALZ-801 prevents amyloid β-protein assembly and reduces cytotoxicity: a preclinical experimental study. FASEB J, 2025; 39, e70382. doi:  10.1096/fj.202402622R
[31] Mishra P, Esfahani EK, Fernyhough P, et al. Estradiol prevents amyloid beta-induced mitochondrial dysfunction and neurotoxicity in Alzheimer’s disease via AMPK-dependent suppression of NF-κB signaling. Int J Mol Sci, 2025; 26, 6203. doi:  10.3390/ijms26136203
[32] Wu A, Lee D, Xiong WC. Lactate metabolism, signaling, and function in brain development, synaptic plasticity, angiogenesis, and neurodegenerative diseases. Int J Mol Sci, 2023; 24, 13398. doi:  10.3390/ijms241713398
[33] Lee JS, Yoon BS, Han SM, et al. Diminished lactate utilization in LDHB-deficient neurons leads to impaired long-term memory retention. Exp Neurol, 2025; 384, 115064. doi:  10.1016/j.expneurol.2024.115064
[34] Li SY, Zheng F, Liu SH, et al. Physical exercise protects neurons from energy deficit and improves cognitive function by upregulating astrocytic Slc2a1 in Alzheimer’s disease. Exp Neurol, 2025; 395, 115493. doi:  10.1016/j.expneurol.2025.115493
[35] Zhang M, Cheng XF, Dang RZ, et al. Lactate deficit in an Alzheimer disease mouse model: the relationship with neuronal damage. J Neuropathol Exp Neurol, 2018; 77, 1163−76. doi:  10.1093/jnen/nly102
[36] Grizzanti J, Moritz WR, Pait MC, et al. KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer’s disease-related pathology. JCI Insight, 2023; 8, e162454. doi:  10.1172/jci.insight.162454
[37] Kim Y, Dube SE, Park CB. Brain energy homeostasis: the evolution of the astrocyte-neuron lactate shuttle hypothesis. Korean J Physiol Pharmacol, 2025; 29, 1−8.
[38] Wang Y, Li P, Xu Y, et al. Lactate metabolism and histone lactylation in the central nervous system disorders: impacts and molecular mechanisms. J Neuroinflammation, 2024; 21, 308. doi:  10.1186/s12974-024-03303-4
[39] Suzuki A, Stern SA, Bozdagi O, et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell, 2011; 144, 810−23. doi:  10.1016/j.cell.2011.02.018
[40] Gu Y, Chen KY, Lei CY, et al. Lactate and lactylation modifications in neurological disorders. Neural Regen Res, 2026; 21, 1681−97. doi:  10.4103/NRR.NRR-D-24-01344
[41] Fox JH, Kama JA, Lieberman G, et al. Mechanisms of copper ion mediated Huntington’s disease progression. PLoS One, 2007; 2, e334. doi:  10.1371/journal.pone.0000334
[42] Lian BL, Zhang J, Yin X, et al. SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2. Cell Rep Med, 2024; 5, 101684. doi:  10.1016/j.xcrm.2024.101684
[43] Cerexhe L, Easton C, Macdonald E, et al. Blood lactate concentrations during rest and exercise in people with Multiple Sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord, 2022; 57, 103454. doi:  10.1016/j.msard.2021.103454
[44] Mathys H, Boix CA, Akay LA, et al. Single-cell multiregion dissection of Alzheimer’s disease. Nature, 2024; 632, 858−68. doi:  10.1038/s41586-024-07606-7
[45] Nixon RA, Rubinsztein DC. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol, 2024; 25, 926−46. doi:  10.1038/s41580-024-00757-5
[46] Valvona CJ, Fillmore HL, Nunn PB, et al. The regulation and function of lactate dehydrogenase a: therapeutic potential in brain tumor. Brain Pathol, 2016; 26, 3−17. doi:  10.1111/bpa.12299
[47] Urbańska K, Orzechowski A. Unappreciated role of LDHA and LDHB to control apoptosis and autophagy in tumor cells. Int J Mol Sci, 2019; 20, 2085. doi:  10.3390/ijms20092085
[48] Jia MS, Yue X, Sun WX, et al. ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation. Sci Adv, 2023; 9, eadg4993. doi:  10.1126/sciadv.adg4993
[49] Tang JX, Thompson K, Taylor RW, et al. Mitochondrial OXPHOS biogenesis: co-regulation of protein synthesis, import, and assembly pathways. Int J Mol Sci, 2020; 21, 3820. doi:  10.3390/ijms21113820
[50] Huang JL, Zhang C, Huang C, et al. Mitochondria metabolism regulates glucose-lipid homeostasis in neurodegenerative diseases. Research, 2025; 8, 0912. doi:  10.34133/research.0912
[51] Wasim R. Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer’s disease. Inflammopharmacology, 2025; 33, 5273−89. doi:  10.1007/s10787-025-01916-6